Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • COLLABORATIVE PUBLISHING PRINCIPLE: ALL the authors must be available to act as peer reviewers for Pharmacy Practice when requested.
  • ORIGINALITY: The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in the box comments to the editor during the submission process).
  • RELEVANCE AND CONSISTENCY: With the purpose of not duplicating literature, authors have checked previous issues of Pharmacy Practice and other pharmacy journals, for similar articles. Referencing these articles acknowledges their previous contribution to the area, as well as gives an idea of the importance that authors assign to pharmacy journals.
  • METADATA: The data are provided to be used under the principles of European Union’s General Data Protection Regulation (GDPR) and will be saved and used within the scope of the standard functioning of peer-reviewed journals.

    Emails for all the authors are provided in the title page and recorded into the submission process. Names of all the authors will be included in following style, according to International Standards:
    Given name.
    Middle name or initial (optional, but only one is accepted)
    Last name
    Download this file to check how names will appear.
    The data are provided to be used under the principles of European Union’s General Data Protection Regulation (GDPR) and will be saved and used within the scope of the standard functioning of peer-reviewed journals.
  • FILES TO SUBMIT: The submission is in OpenOffice, Microsoft Word, RTF or WordPerfect document file format.
    Title page, abstract, main text, tables and figures (embedded) should be submitted in ONLY ONE FILE.
    Optional supplementary files can be submitted separately.

    Do not submit a cover letter. Just include the text in the box "Comments for the Editor".

  • TITLE PAGE: Title page contains all required information, including: title, conflict of interest statement, funding information, and corresponding author contact details.
    Authors’ information includes name, degree, current position, institution, and e-mail.
  • ABSTRACT: Abstract is ALWAYS structured with the following subheadings: Objective, Methods, Results, and Conclusion.
    Keywords are obtained from the MeSH database.
  • MAIN TEXT: The manuscript of original research articles is ALWAYS structured in the following manner: Introduction, Methods, Results, Discussion and Conclusions. Do not aggregate these subheadings.

    Text does not include abbreviations, unless they are commonly accepted.

  • REFERENCES: All references are cited in the text, and they appear in the references section in the same order as they appear in the text.
    References are cited in standard MEDLINE form, including all their authors (avoiding the use of “et al”).
    Internet pages used as references mention the date of access.
  • TABLES AND FIGURESTables appear at the end of the Main Text file, and they are formatted following the new specific rules for tables. Figures appear at the end of the Main Text file and they are pasted in the manuscript as Microsoft Objects that allow editing.
  • CONSENT: I have read and agree to the privacy policy

Author Guidelines

Pharmacy Practice does not charge and will never charge any publication fee or article processing charge (APC) to its authors.

Ethics in Publishing:

Pharmacy Practice supports and is supported by the fundamentals of scholarly publishing. Authors considering submitting a paper to Pharmacy Practice must follow a strict code of conduct based on the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals, especially in regards to Roles & Responsibilities and the Scientific Misconduct of the authors and collaborators.

  • Originality of the text in manuscripts is checked by the text-similarity detection service Crossref Similarity Check.
  • Correspondence author is responsible for including all the authors that are granted the right to be authors, but also for not including any individual who does not deserve  authorship. Notwithstanding, Pharmacy Practice has no limit in the number of authors per paper, we recommend double-checking the criteria to consider a contributor as an author and also to consider if the role of collaborator or a simple acknowledgement are more appropriate.
  • If a scientific misconduct is suspected, COPE flowcharts will be applied with no restriction, as we did in the past (Pharm Pract (Granada) 2012;10(1):1-2).

Ethical publishing requires using ethical procedures and instruments. Ethics approval is mandatory when the study includes humans; otherwise, specific information should be provided if ethics approval is not required. Registration of clinical trials and systematic reviews is also needed. Articles reporting the use of instruments potentially associated with unethical behavior or poor academic integrity (e.g. MMAS and MMAS-8) will not be considered for publication. Manuscripts using a questionnaire, scale or any other type of data-gathering instrument must provide the language version used as online supplementary material. No restrictions are accepted for the use of any of these instruments.


Categories of articles:

  • Editorials: Written by the editorial board or solicited by the editor-in-chief.
  • Reviews: Narrative reviews of topics under the scope of the journal. Reviews require a presubmission inquiry addressed to the editor-in-chief, including a list of PubMed indexed publications that demonstrate author expertise in the topic.
  • Original research articles: Presenting the results of an original research recently performed. A structured abstract is required (i.e., Background, Objectives, Methods, Results, Conclusions). This category includes full articles and short reports. No limits exist in the word count or in the number of authors.
  • Official statements, positions and reports: Full-length reports produced by societies or institutions. They require a presubmission inquiry addressed to the editor-in-chief.
  • Letters to the Editor (in reply): Letters discussing a recently published article will be considered only if they are received within six weeks of the article’s publication. Letters should not exceed 400 words of text and five references. No abstract is required.

Pharmacy Practice does not publish case reports, opinions, commentaries or controversies.


Some other recommendations for all the manuscripts:

Authors are encouraged to visit the Instructions for Reviewers page to see how these crucial collaborators will evaluate the manuscript.

Additional recommendations, applicable to any category of article:

  • Abstracts should have no more than 350 words and no fewer than 250 (in original research articles, abstracts should be structured in the following manner: Background, Objective, Methods, Results, and Conclusion).
  • Only keywords based on NLM Medical Subject Headings are used.
  • References should be cited in the main text as numbers in superscript at the end of sentences after the period in all cases. The list of references should be numbered and ordered as they are cited in the text.
  • Reference format should follow ICMJE recommendations (Citing Medicine) and journal titles must be abbreviated according to the MEDLINE style, available at the NLM Catalog.
  • Tables must appear at the end of the text, formatted as follows:
      • Use simple grids without merging cells. No cell shading is allowed.
      • Font must be Calibri, 8pt, simple line spacing.
      • Orientation of the page containing the table must be portrait.
      • Table should fit onto one page. Oversized tables will be moved to an online appendix.
  • Figures are preferred pasted as Microsoft Objects. Color use should take into account that papers can be printed in black and white.
  • Avoid the use of abbreviations. Use only abbreviations commonly accepted. Do not create new abbreviations.
  • Avoid the use of non-Roman characters. Do not use Greek letters in the text. They can be used in equations. Do not use special characters, such as ± ½ ¼ or arrows.
  • Present standard deviations as (SD=2.34) and confidence intervals as [95%CI 2.36:4.23]
  • For currency abbreviations, use the ISO 4217 codes.
  • Follow international standards for author names and abbreviations. "John Philip Doe" should be abbreviated as "Doe JP". Download this Excel file to see how your name will be abbreviated following international standards.
  • [NEW RULE for 2020] Provide only one institution for each author’s affiliation. Affiliations must be translated into English. There are no exceptions to this rule. Candidate positions are not considered.
  • For non-native English authors, a scientific editing service could be required. See below a list of some of these scientific editing providers. Authors using this service should include a sentence in the acknowledgements section. Pharmacy Practice offers a 10% discount on American Journal Experts services to its authors by using this link.

Privacy Statement

Privacy police

The data collected from registered and nonregistered users of Pharmacy Practice falls within the scope of the standard functioning of peer-reviewed journals. It includes information that makes communication possible for the editorial process. It is used to informs readers about the authorship and editing of content, and enables collecting aggregated data on readership behaviors, as well as tracking geopolitical and social elements of scholarly communication.

Pharmacy Practice's editorial team uses this data to guide its work in publishing and improving this journal. Data that will assist in developing this publishing platform could be shared with its developer, Public Knowledge Project, in an anonymized and aggregated form, with appropriate exceptions such as article metrics. The data will not be sold by this journal or PKP, nor will it be used for purposes other than those stated here. The authors published in this journal are responsible for the human subject data that figures in the research reported here.

Those involved in editing this journal seek to be compliant with industry standards for data privacy, including the European Union’s General Data Protection Regulation (GDPR) provision for “data subject rights” that include (a) breach notification, (b) right of access, (c) the right to be forgotten, (d) data portability, and (e) privacy by design. The GDPR also allows for the recognition of “the public interest in the availability of the data,” which has a particular saliency for those involved in maintaining, with the greatest integrity possible, the public record of scholarly publishing.